Posts Tagged ‘Acorda’

Pre-Market Volume Spike: Acorda Therapeutics (ACOR)

Acorda Therapeutics (NASDAQ: ACOR) is seeing shares surge on active pre-market trading volume on news this Monday morning.  The company announced positive data from a second Phase III study of its Fampridine-SR as a treatment for patients’ walking abilities who suffer from multiple sclerosis. Acorda trades has an average daily volume of about about 570,000 [...]